Novo Nordisk A/S 's Rybelsus, the first oral GLP-1 treatment for type 2 diabetes, has got off to a strong start and the Danish firm has moved to acquire the company that developed the innovative formu
The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between Feb. 3 and Feb. 9, 2017, divided b
SHANGHAI - Oramed Pharmaceuticals Inc. , the Israeli developer of an oral insulin capsule, ORMD-0801, for both type 1 and 2 diabetes, and China-based Hefei Tianhui Incubator of Technologies (HTIT)
IN VITRO DIAGNOSTICS Mergers & Acquisitions DNA Diagnostics Center MTS Health Investors sold DNA Diagnostics Center (DDC) to London-based GHO Capital for $110mm (€104mm). (Oct.) Through the acquis